Dalton Pharma Services introduces new medicinal chemistry services

By Wai Lang Chu

- Last updated on GMT

Related tags: Pharmacology

Dalton Pharma Services has introduced a range of new medicinal
chemistry services that are available to companies involved in drug
discovery that wish to utilise additional scientific and managerial
expertise as well as specialised equipment.

The deal aims to strengthen Dalton's offerings within the outsourcing sector, which already includes cGMP manufacturing and sterile filling services to clients at Phase I, II or III of the regulatory process.

The formation of Dalton Medicinal Chemistry Partners is the result of a joint venture with Dr. Judd Berman, a scientist who has held positions at Merrell Dow, Glaxo, GlaxoWellcome, GSK and most recently Affinium Pharmaceuticals.

"Judd's broad experience and abilities in drug discovery using medicinal chemistry, as well as his track record in identification and optimisation of high quality lead compounds, combined with Dalton's 20 year history of success in drug development, creates a powerful combination,"​ said Peter Pekos, President and CEO of Dalton Pharma Services.

"Taking full advantage of our state of the art facilities, this new venture makes significant additional scientific and managerial expertise available to our clients and augments Dalton's ability to identify and deliver promising small molecules quickly for our partners' programs,"​ added Pekos.

Dalton Pharma Services is a contract pharmaceutical manufacturer that supplies chemistry and analytical services to the biotechnology and pharmaceutical industries in the areas of medicinal chemistry, fine chemical manufacture, custom peptides and antisense oligo production.

Dalton's services include producing active pharmaceutical ingredients (API), at the gram or kilogram scale.

Dalton can also carry out sterile fills to produce batches of finished drug product in vials or syringes, either aseptically filled or terminally sterilised, under fully validated conditions.

In addition, Dalton's analytical chemistry laboratory offers method development, validation and ICH stability programs to its clients.

Related news

Show more

Related products

show more

Has EDC Kept Up With Changes In Clinical Trials?

Has EDC Kept Up With Changes In Clinical Trials?

Oracle Health Sciences | 14-Dec-2020 | Technical / White Paper

In just a few decades, clinical trials have changed dramatically. Twenty years ago, most of the data used in clinical research was entered on paper, but...

Why Blister Packaging: Things to Consider

Why Blister Packaging: Things to Consider

Catalent Pharma Solutions | 03-Dec-2020 | Insight Guide

The decision to use blister packaging for either clinical trials or commercial drug manufacturing comes with a host of factors to consider. Pharmaceutical...

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

Related suppliers

Follow us


View more